{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:43:58Z","timestamp":1778823838256,"version":"3.51.4"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/2.zoppoz.workers.dev:443\/https\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/2.zoppoz.workers.dev:443\/https\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/2.zoppoz.workers.dev:443\/http\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.neuroimage.2021.118646","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:54:32Z","timestamp":1634000072000},"page":"118646","update-policy":"https:\/\/2.zoppoz.workers.dev:443\/https\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et\u00a0al. 2021"],"prefix":"10.1016","volume":"245","author":[{"given":"Benjamin B.","family":"Risk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deqiang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.neuroimage.2021.118646_bib0001","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/brain\/awx137","article-title":"Cerebral quantitative susceptibility mapping predicts amyloid-\u03b2-related cognitive decline","volume":"140","author":"Ayton","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neuroimage.2021.118646_bib0002","doi-asserted-by":"crossref","first-page":"117433","DOI":"10.1016\/j.neuroimage.2020.117433","article-title":"Associations of quantitative susceptibility mapping with Alzheimer\u2019s disease clinical and imaging markers","volume":"224","author":"Cogswell","year":"2021","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.neuroimage.2021.118646_bib0003","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/jmri.24859","article-title":"Test-retest reliability of diffusion measures in cerebral white matter: a multiband diffusion MRI study","volume":"42","author":"Duan","year":"2015","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1","key":"10.1016\/j.neuroimage.2021.118646_bib0004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.zemedi.2017.05.003","article-title":"Quantitative susceptibility mapping (QSM) and R2* in the human brain at 3 T: evaluation of intra-scanner repeatability","volume":"28","author":"Feng","year":"2018","journal-title":"Z. Med. Phys."},{"key":"10.1016\/j.neuroimage.2021.118646_bib0005","doi-asserted-by":"crossref","first-page":"117358","DOI":"10.1016\/j.neuroimage.2020.117358","article-title":"Multi-centre, multi-vendor reproducibility of 7T QSM and R2* in the human brain: results from the UK7T study","volume":"223","author":"Rua","year":"2020","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.neuroimage.2021.118646_bib0006","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/hbm.23948","article-title":"Test-retest reliability and longitudinal analysis of automated hippocampal subregion volumes in healthy ageing and Alzheimer\u2019s disease populations","volume":"39","author":"Worker","year":"2018","journal-title":"Hum. Brain Mapp."}],"container-title":["NeuroImage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/2.zoppoz.workers.dev:443\/https\/api.elsevier.com\/content\/article\/PII:S1053811921009198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/2.zoppoz.workers.dev:443\/https\/api.elsevier.com\/content\/article\/PII:S1053811921009198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:56:37Z","timestamp":1760957797000},"score":1,"resource":{"primary":{"URL":"https:\/\/2.zoppoz.workers.dev:443\/https\/linkinghub.elsevier.com\/retrieve\/pii\/S1053811921009198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":6,"alternative-id":["S1053811921009198"],"URL":"https:\/\/2.zoppoz.workers.dev:443\/https\/doi.org\/10.1016\/j.neuroimage.2021.118646","relation":{},"ISSN":["1053-8119"],"issn-type":[{"value":"1053-8119","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et\u00a0al. 2021","name":"articletitle","label":"Article Title"},{"value":"NeuroImage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/2.zoppoz.workers.dev:443\/https\/doi.org\/10.1016\/j.neuroimage.2021.118646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118646"}}